RAYMOND JAMES & ASSOCIATES - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 133 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2020. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q1 2021$35,000
+59.1%
17,6810.0%0.00%
Q4 2020$22,000
-70.7%
17,681
-57.5%
0.00%
Q3 2020$75,000
-84.3%
41,598
-27.1%
0.00%
-100.0%
Q2 2020$479,000
+131.4%
57,098
+44.2%
0.00%
Q1 2020$207,000
-38.4%
39,598
-35.7%
0.00%
Q4 2019$336,000
+6.3%
61,598
-4.9%
0.00%
Q3 2019$316,000
-44.9%
64,798
-21.8%
0.00%
-100.0%
Q2 2019$574,000
+24.0%
82,824
+24.4%
0.00%0.0%
Q1 2019$463,000
+3.6%
66,579
-13.0%
0.00%0.0%
Q4 2018$447,000
+42.4%
76,494
+84.1%
0.00%
Q3 2018$314,000
+234.0%
41,543
+123.4%
0.00%
Q2 2018$94,000
-3.1%
18,598
+17.1%
0.00%
Q1 2018$97,000
-90.7%
15,885
-87.4%
0.00%
-100.0%
Q1 2017$1,038,000
-12.0%
125,830
-9.9%
0.00%
-33.3%
Q4 2016$1,180,000
+671.2%
139,680
+65.4%
0.00%
+200.0%
Q1 2016$153,00084,4500.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q3 2020
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$1,273,0000.73%
ETF MANAGERS GROUP, LLC 7,062,485$1,787,0000.05%
Ikarian Capital, LLC 862,527$217,0000.04%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 457,209$115,0000.02%
Platform Technology Partners 33,750$9,0000.01%
PINNACLE ASSOCIATES LTD 910,006$230,0000.01%
CJM Wealth Advisers, Ltd. 30,465$7,6830.01%
Mirae Asset Global Investments Co., Ltd. 4,029,171$1,016,0000.00%
Vident Investment Advisory, LLC 267,612$67,0000.00%
Aries Wealth Management 15,400$4,0000.00%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders